Cargando…

ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer

BACKGROUND: Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) are potential tools to minimize the side effects and substantially enhance the therapeutic efficacy of chemotherapy. However, it is challenging to achieve spatially and temporally controllable and accurate drug release...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Hanxi, Lu, Wangxing, Liu, Fan, Zhang, Guoqing, Xie, Feifan, Liu, Wenjie, Wang, Lei, Zhou, Wenhu, Cheng, Zeneng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111982/ https://www.ncbi.nlm.nih.gov/pubmed/33975609 http://dx.doi.org/10.1186/s12951-021-00877-6

Ejemplares similares

Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy
por: Lu, Wangxing, et al.
Publicado: (2023)

NIR light-activatable dissolving microneedle system for melanoma ablation enabled by a combination of ROS-responsive chemotherapy and phototherapy
por: Liu, Fan, et al.
Publicado: (2023)

Liposome-Tethered Gold Nanoparticles Triggered by Pulsed NIR Light for Rapid Liposome Contents Release and Endosome Escape
por: Veeren, Anisha, et al.
Publicado: (2022)

NIR responsive liposomal system for rapid release of drugs in cancer therapy
por: Chen, Ming-Mao, et al.
Publicado: (2017)

NIR-II light-modulated thermosensitive hydrogel for light-triggered cisplatin release and repeatable chemo-photothermal therapy
por: Ruan, Changping, et al.
Publicado: (2019)

Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin
por: van Elk, Merel, et al.
Publicado: (2015)

A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data
por: Liu, Fan, et al.
Publicado: (2023)

NIR laser-responsive liquid metal-loaded polymeric hydrogels for controlled release of doxorubicin
por: Fan, Linlin, et al.
Publicado: (2019)

A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice
por: Kress, Jeremy, et al.
Publicado: (2017)

NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes
por: Kim, Min Ah., et al.
Publicado: (2022)

Near-Infrared Activated Release of Doxorubicin from Plasmon Resonant Liposomes
por: Knights-Mitchell, Shellie S., et al.
Publicado: (2018)

Light-Triggerable Liposomes for Enhanced Endolysosomal Escape and Gene Silencing in PC12 Cells
por: Chen, Wenjie, et al.
Publicado: (2017)

Pharmacokinetics of a liposomal formulation of doxorubicin in rats
por: Liu, Zongyu, et al.
Publicado: (2017)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Release of doxorubicin from its liposomal coating via high intensity ultrasound
por: Mikolajczyk, Agata, et al.
Publicado: (2019)

Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin
por: Hekmatirad, Shirin, et al.
Publicado: (2021)

DNA–Liposome Hybrid Carriers for Triggered Cargo Release
por: Baumann, Kevin N., et al.
Publicado: (2022)

Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity
por: Wang, Chaoyu, et al.
Publicado: (2023)

NIR/pH-triggered aptamer-functionalized DNA origami nanovehicle for imaging-guided chemo-phototherapy
por: Li, Mengyue, et al.
Publicado: (2023)

Light-Activated Content Release from Liposomes
por: Leung, Sarah J., et al.
Publicado: (2012)

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
por: Rafiyath, Shamudheen M, et al.
Publicado: (2012)

Light-triggered hydrophilic drug release from liposomes through removal of a photolabile protecting group
por: Goto, Yuya, et al.
Publicado: (2018)

NIR-triggered upconversion nanoparticles@thermo-sensitive liposome hybrid theranostic nanoplatform for controlled drug delivery
por: Yu, Yibin, et al.
Publicado: (2021)

Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles as a pH-triggered drug self-delivery system
por: Li, Jiagen, et al.
Publicado: (2022)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Ultralow-intensity NIR light triggered on-demand drug release by employing highly emissive UCNP and photocleavable linker with low bond dissociation energy
por: Shi, Junhui, et al.
Publicado: (2019)

pH-Triggered Echogenicity and Contents Release from Liposomes
por: Nahire, Rahul, et al.
Publicado: (2014)

Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation
por: Deng, Wei, et al.
Publicado: (2018)

Palladium nanoparticle based smart hydrogels for NIR light-triggered photothermal/photodynamic therapy and drug release with wound healing capability
por: Yin, Xiuzhao, et al.
Publicado: (2023)

Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy
por: Liang, Meng, et al.
Publicado: (2022)

Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials
por: Weinstain, Roy, et al.
Publicado: (2020)

Oxygen self-sufficient NIR-activatable liposomes for tumor hypoxia regulation and photodynamic therapy
por: Yu, Qi, et al.
Publicado: (2019)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Focal induction of ROS-release to trigger local vascular degeneration
por: Minol, Jan-Philipp, et al.
Publicado: (2017)

Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches
por: Peng, Yaru, et al.
Publicado: (2021)

Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: He, Sha, et al.
Publicado: (2022)

Assessment of Intratumoral Doxorubicin Penetration after Mild Hyperthermia-Mediated Release from Thermosensitive Liposomes
por: Derieppe, Marc, et al.
Publicado: (2019)

Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
por: Ibrahim, Mihad, et al.
Publicado: (2022)

NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma
por: Wang, Chonggao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gja40a135vbbe11oi83eb2pmbo